British Columbia Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38M Sell
53,749
-15,718
-23% -$1.09M 0.02% 462
2025
Q4
$4.61M Buy
69,467
+13,114
+23% +$848K 0.02% 427
2025
Q3
$3.79M Sell
56,353
-5,340
-9% -$423K 0.02% 422
2025
Q2
$5.39M Sell
61,693
-13,011
-17% -$1.02M 0.03% 353
2025
Q1
$5.1M Sell
74,704
-2,025
-3% -$165K 0.03% 389
2024
Q4
$5.97M Buy
76,729
+10,375
+16% +$768K 0.04% 371
2024
Q3
$4.45M Sell
66,354
-7,481
-10% -$614K 0.03% 405
2024
Q2
$8.37M Buy
73,835
+27,559
+60% +$3.48M 0.05% 271
2024
Q1
$6.42M Buy
46,276
+1,619
+4% +$204K 0.04% 278
2023
Q4
$5.54M Buy
44,657
+9,414
+27% +$962K 0.05% 276
2023
Q3
$3.29M Buy
35,243
+283
+0.8% +$31.9K 0.03% 347
2023
Q2
$4.49M Buy
34,960
+556
+2% +$67.2K 0.04% 284
2023
Q1
$4M Sell
34,404
-372
-1% -$41.6K 0.04% 302
2022
Q4
$3.94M Sell
34,776
-3,915
-10% -$430K 0.04% 296
2022
Q3
$3.12M Sell
38,691
-6,365
-14% -$539K 0.04% 353
2022
Q2
$3.36M Sell
45,056
-14,792
-25% -$1.35M 0.03% 376
2022
Q1
$7.66M Sell
59,848
-8,148
-12% -$891K 0.05% 294
2021
Q4
$9.13M Sell
67,996
-3,564
-5% -$512K 0.05% 297
2021
Q3
$9.78M Buy
71,560
+404
+0.6% +$50.9K 0.06% 279
2021
Q2
$7.6M Buy
71,156
+8,248
+13% +$792K 0.05% 334
2021
Q1
$5.65M Sell
62,908
-1,920
-3% -$180K 0.04% 361
2020
Q4
$5.99M Buy
64,828
+764
+1% +$68.2K 0.04% 327
2020
Q3
$6.6M Buy
64,064
+5,352
+9% +$559K 0.05% 279
2020
Q2
$5.95M Buy
58,712
+18,656
+47% +$1.67M 0.06% 281
2020
Q1
$2.7M Sell
40,056
-45,892
-53% -$2.86M 0.05% 290
2019
Q4
$4.7M Sell
85,948
-2,496
-3% -$118K 0.04% 391
2019
Q3
$3.3M Sell
88,444
-24,832
-22% -$965K 0.03% 448
2019
Q2
$4.24M Buy
113,276
+30,096
+36% +$946K 0.04% 483
2019
Q1
$2.48M Sell
83,180
-5,840
-7% -$205K 0.02% 618
2018
Q4
$2.67M Buy
+89,020
New +$2.82M 0.02% 601
2017
Q4
Sell
-113,972
Closed -$1.39M 693
2017
Q3
$1.39M Buy
113,972
+57,364
+101% +$1.01M 0.01% 658
2017
Q2
$1.03M Sell
56,608
-96,616
-63% -$1.78M 0.01% 669
2017
Q1
$3.25M Sell
153,224
-96,780
-39% -$1.89M 0.03% 564
2016
Q4
$3.73M Buy
+250,004
New +$4.43M 0.03% 537

Other funds holding DXCM

British Columbia Investment Management's DXCM Position: Q1 2026 in Review

British Columbia Investment Management reduced its DexCom (DXCM) stake by 23% in Q1 2026, selling an estimated $1.09M and leaving 53,749 shares worth $3.38M. The position accounts for 0.02% of the portfolio, ranked #462.

British Columbia Investment Management first reported a position in DXCM in Q4 2016 and has held it in 34 quarters since. The position peaked at $9.78M in Q3 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • British Columbia Investment Management held 53,749 shares of DexCom worth $3.38M as of Q1 2026.
  • British Columbia Investment Management sold 15,718 DexCom shares in Q1 2026, an estimated $1.09M.
  • DexCom made up 0.02% of British Columbia Investment Management's portfolio in Q1 2026, its #462 holding.
  • British Columbia Investment Management first reported a position in DexCom in Q4 2016 and has held it in 34 quarters since.
  • British Columbia Investment Management's DexCom position peaked at $9.78M in Q3 2021.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.